Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | July 28, 2022 08:09am

 

Gainers

  • Better Therapeutics (NASDAQ:BTTX) shares moved upwards by 67.3% to $2.56 during Thursday's pre-market session. The company's market cap stands at $60.4 million.
  • Revelation Biosciences (NASDAQ:REVBU) shares increased by 50.01% to $1.5.
  • Athersys (NASDAQ:ATHX) shares increased by 27.68% to $0.24. The company's market cap stands at $64.0 million.
  • Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 13.99% to $1.1. The company's market cap stands at $65.2 million.
  • Avalon Globocare (NASDAQ:AVCO) shares rose 13.8% to $0.55. The market value of their outstanding shares is at $48.9 million.
  • Kintara Therapeutics (NASDAQ:KTRA) shares rose 10.7% to $0.21. The market value of their outstanding shares is at $13.7 million.

Losers

  • Community Health Systems (NYSE:CYH) stock fell 47.3% to $2.73 during Thursday's pre-market session. The company's market cap stands at $367.7 million. The company's, Q2 earnings came out yesterday.
  • Teladoc Health (NYSE:TDOC) stock declined by 23.11% to $33.25. The company's market cap stands at $5.3 billion. As per the news, the Q2 earnings report came out yesterday.
  • Lexicon Pharmaceuticals (NASDAQ:LXRX) shares decreased by 19.27% to $2.64. The market value of their outstanding shares is at $394.9 million.
  • Blue Water Vaccines (NASDAQ:BWV) stock declined by 14.02% to $2.7. The market value of their outstanding shares is at $33.2 million.
  • Fresenius Medical Care (NYSE:FMS) stock declined by 13.79% to $19.39. The market value of their outstanding shares is at $11.3 billion.
  • Smith & Nephew (NYSE:SNN) stock declined by 12.24% to $25.76. The company's market cap stands at $11.2 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKTX ATHX AVCO BTTX BWV CYH FMS KTRA LXRX REVBU SNN TDOC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist